Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5144104 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL2169353 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL5143766 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL13293980 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL5144071 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL2121215 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL18998974 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL5144176 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL21373974 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL10707120 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115166263-B | Kit for measuring concentration of glycosylated hemoglobin and method thereof | 美康生物科技股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-117106772-B | Sample releasing agent for detecting virus nucleic acid | 青岛金域医学检验实验室有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-112080585-B | Novel coronavirus (SARS-CoV-2) rapid detection kit and method thereof | 上海市公共卫生临床中心 | 2023-11-07 | — | — | CN | claimed |
| CN-114839374-A | Method for accurate diagnosis of disease-targeted biomarkers in liquid biopsies | 相达生物科技国际有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-110462400-B | Method for accurate diagnosis of disease-targeted biomarkers in liquid biopsies | 相达生物科技国际有限公司 | 2022-06-21 | — | — | CN | claimed |
| EP-3463317-A1 | METHOD FOR PREPARATION OF QUICK DISSOLVING THIN FILMS CONTAINING BIOACTIVE MATERIAL WITH ENHANCED THERMAL STABILITY | Aridis Pharmaceuticals, Inc. (US) | 2019-04-10 | — | — | EP | claimed |
| WO-2017214187-A1 | METHOD FOR PREPARATION OF QUICK DISSOLVING THIN FILMS CONTAINING BIOACTIVE MATERIAL WITH ENHANCED THERMAL STABILITY | ARIDIS PHARMACEUTICALS, INC. (US) | 2017-12-14 | — | — | WO | claimed |
| US-20140356396-A1 | ROTAVIRUS PREPARATIONS WITH EXCESS CALCIUM IONS AND HIGH VISCOSITIES THAT ENSURE VIABILITY AT ELEVATED TEMPERATURES | PULLIAM BRIAN L (US) | 2014-12-04 | — | — | US | claimed |
| EP-2747777-A2 | ROTAVIRUS PREPARATIONS WITH EXCESS CALCIUM IONS AND HIGH VISCOSITIES THAT ENSURE VACCINE VIABILITY AT ELEVATED TEMPERATURES | Pulliam, Brian (US) | 2014-07-02 | — | — | EP | claimed |
| EP-2197283-B1 | FORMULATIONS FOR PRESERVATION OF ROTA VIRUS | ARIDIS PHARMACEUTICALS (US) | 2013-07-17 | — | — | EP | claimed |
| EP-1206189-A4 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO INC (US) | 2003-03-12 | — | — | EP | claimed |
| US-20020136741-A1 | Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci | AMERICAN CYANAMID COMPANY (US) | 2002-09-26 | — | — | US | claimed |
| EP-1206189-A1 | ROTAVIRUS VACCINE FORMULATIONS | Merck & Co., Inc. (US) | 2002-05-22 | — | — | EP | claimed |
| US-6355253-B1 | BACTERICIDAL ANTIBODIES | AMERICAN CYANAMID COMPANY | 2002-03-12 | — | — | US | claimed |
| WO-2002011540-A1 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO., INC. (US) | 2002-02-14 | — | — | WO | claimed |
| WO-2001008495-A1 | ROTAVIRUS VACCINE FORMULATIONS | MERCK & CO., INC. (US) | 2001-02-08 | — | — | WO | claimed |
| US-5521067-A | Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally | UNIVERSITY OF ROCHESTER (US) | 1996-05-28 | — | — | US | claimed |
| WO-1995014711-A1 | CELL ADHESION MOLECULES AND DETECTING ADHERENCE | UNIVERSITY OF ROCHESTER (US) | 1995-06-01 | — | — | WO | claimed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | claimed |
| US-5335373-A | Protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020136741-A1 | Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci | DDOST, STT3B, STT3A | MEN1 994/4885KMT2A 4498/4885ALDH1A1 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.